Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0051726
|
regulation of cell cycle |
CCND1,CDK6,CCNE2,HNF4A,BCL2,CDC25A,BIRC5,HDAC1,CDK4,GMNN, |
6.40E-10 |
GO:0042127
|
regulation of cell proliferation |
CCND1,CDK6,HNF4A,BCL2,MYCN,PDGFRA,WISP2,NOTCH1,NF2,HDAC1,CDK4,SIRT1, |
4.97E-9 |
GO:0051329
|
interphase of mitotic cell cycle |
CCND1,CDK6,BCL2,CDC25A,BIRC5,CDK4, |
4.28E-7 |
GO:0051325
|
interphase |
CCND1,CDK6,BCL2,CDC25A,BIRC5,CDK4, |
4.94E-7 |
GO:0008284
|
positive regulation of cell proliferation |
CCND1,CDK6,BCL2,MYCN,PDGFRA,NOTCH1,HDAC1,CDK4, |
1.91E-6 |
|
GO:0051301
|
cell division |
CCND1,CDK6,CCNE2,CDC25A,NOTCH1,BIRC5,CDK4, |
4.20E-6 |
GO:0045786
|
negative regulation of cell cycle |
CDK6,HNF4A,BCL2,HDAC1,GMNN, |
6.60E-6 |
GO:0045596
|
negative regulation of cell differentiation |
CCND1,CDK6,NOTCH3,NOTCH1,HDAC1,SIRT1, |
1.63E-5 |
GO:0042325
|
regulation of phosphorylation |
CCND1,CCNE2,HNF4A,BCL2,CDC25A,NF2,MET, |
5.64E-5 |
GO:0051174
|
regulation of phosphorus metabolic process |
CCND1,CCNE2,HNF4A,BCL2,CDC25A,NF2,MET, |
7.05E-5 |
GO:0019220
|
regulation of phosphate metabolic process |
CCND1,CCNE2,HNF4A,BCL2,CDC25A,NF2,MET, |
7.05E-5 |
GO:0000082
|
G1/S transition of mitotic cell cycle |
CCND1,BCL2,CDC25A,CDK4, |
8.47E-5 |
GO:0007049
|
cell cycle |
CCND1,CDK6,CCNE2,BCL2,CDC25A,BIRC5,CDK4,GMNN, |
1.13E-4 |
GO:0042063
|
gliogenesis |
CDK6,PDGFRA,NOTCH1,NF2, |
1.32E-4 |
GO:0031099
|
regeneration |
CCND1,BCL2,NOTCH3,NOTCH1, |
1.58E-4 |
GO:0000278
|
mitotic cell cycle |
CCND1,CDK6,BCL2,CDC25A,BIRC5,CDK4, |
2.11E-4 |
GO:0016575
|
histone deacetylation |
HDAC1,SIRT1,HDAC8, |
3.07E-4 |
GO:0022403
|
cell cycle phase |
CCND1,CDK6,BCL2,CDC25A,BIRC5,CDK4, |
3.55E-4 |
GO:0010551
|
regulation of specific transcription from RNA polymerase II promoter |
HNF4A,NOTCH1,HDAC1,SIRT1, |
3.94E-4 |
GO:0006476
|
protein amino acid deacetylation |
HDAC1,SIRT1,HDAC8, |
5.20E-4 |
GO:0048742
|
regulation of skeletal muscle fiber development |
BCL2,NOTCH1,HDAC1, |
6.73E-4 |
GO:0048146
|
positive regulation of fibroblast proliferation |
CDK6,PDGFRA,CDK4, |
7.29E-4 |
GO:0001952
|
regulation of cell-matrix adhesion |
CDK6,BCL2,NF2, |
7.86E-4 |
GO:0048641
|
regulation of skeletal muscle tissue development |
BCL2,NOTCH1,HDAC1, |
9.08E-4 |
GO:0045137
|
development of primary sexual characteristics |
CCND1,BCL2,PDGFRA,SIRT1, |
9.49E-4 |
GO:0042981
|
regulation of apoptosis |
BCL2,NOTCH1,BIRC5,HDAC1,XIAP,SIRT1,BMF, |
1.08E-2 |
GO:0051153
|
regulation of striated muscle cell differentiation |
BCL2,NOTCH1,HDAC1, |
1.10E-2 |
GO:0032583
|
regulation of gene-specific transcription |
HNF4A,NOTCH1,HDAC1,SIRT1, |
1.10E-2 |
GO:0043067
|
regulation of programmed cell death |
BCL2,NOTCH1,BIRC5,HDAC1,XIAP,SIRT1,BMF, |
1.14E-2 |
GO:0010941
|
regulation of cell death |
BCL2,NOTCH1,BIRC5,HDAC1,XIAP,SIRT1,BMF, |
1.16E-2 |
GO:0048145
|
regulation of fibroblast proliferation |
CDK6,PDGFRA,CDK4, |
1.32E-2 |
GO:0022402
|
cell cycle process |
CCND1,CDK6,BCL2,CDC25A,BIRC5,CDK4, |
1.45E-2 |
GO:0010604
|
positive regulation of macromolecule metabolic process |
CCND1,HNF4A,BCL2,PDGFRA,NOTCH1,HDAC1,CDK4, |
1.51E-2 |
GO:0007548
|
sex differentiation |
CCND1,BCL2,PDGFRA,SIRT1, |
1.56E-2 |
GO:0007346
|
regulation of mitotic cell cycle |
CCND1,HNF4A,BCL2,BIRC5, |
1.59E-2 |
GO:0051147
|
regulation of muscle cell differentiation |
BCL2,NOTCH1,HDAC1, |
1.64E-2 |
GO:0045859
|
regulation of protein kinase activity |
CCND1,CCNE2,CDC25A,NF2,MET, |
1.76E-2 |
GO:0043066
|
negative regulation of apoptosis |
BCL2,NOTCH1,BIRC5,HDAC1,XIAP, |
1.93E-2 |
GO:0043549
|
regulation of kinase activity |
CCND1,CCNE2,CDC25A,NF2,MET, |
1.99E-2 |
GO:0043069
|
negative regulation of programmed cell death |
BCL2,NOTCH1,BIRC5,HDAC1,XIAP, |
2.04E-2 |
GO:0060548
|
negative regulation of cell death |
BCL2,NOTCH1,BIRC5,HDAC1,XIAP, |
2.06E-2 |
GO:0008285
|
negative regulation of cell proliferation |
CDK6,HNF4A,BCL2,WISP2,NF2, |
2.08E-2 |
GO:0010810
|
regulation of cell-substrate adhesion |
CDK6,BCL2,NF2, |
2.27E-2 |
GO:0001932
|
regulation of protein amino acid phosphorylation |
CCND1,HNF4A,BCL2,NF2, |
2.30E-2 |
GO:0051338
|
regulation of transferase activity |
CCND1,CCNE2,CDC25A,NF2,MET, |
2.32E-2 |
GO:0016202
|
regulation of striated muscle tissue development |
BCL2,NOTCH1,HDAC1, |
2.68E-2 |
GO:0048634
|
regulation of muscle development |
BCL2,NOTCH1,HDAC1, |
2.79E-2 |
GO:0006796
|
phosphate metabolic process |
CCND1,CDK6,BCL2,PDGFRA,CDC25A,CDK4,MET, |
2.89E-2 |
GO:0006793
|
phosphorus metabolic process |
CCND1,CDK6,BCL2,PDGFRA,CDC25A,CDK4,MET, |
2.89E-2 |
GO:0006468
|
protein amino acid phosphorylation |
CCND1,CDK6,BCL2,PDGFRA,CDK4,MET, |
3.02E-2 |
GO:0042060
|
wound healing |
HNF4A,NOTCH3,PDGFRA,NOTCH1, |
3.05E-2 |
GO:0000079
|
regulation of cyclin-dependent protein kinase activity |
CCND1,CCNE2,CDC25A, |
3.12E-2 |
GO:0031667
|
response to nutrient levels |
CCND1,BCL2,SIRT1,ATG9A, |
3.33E-2 |
GO:0034330
|
cell junction organization |
HNF4A,BCL2,NF2, |
3.47E-2 |
GO:0010552
|
positive regulation of specific transcription from RNA polymerase II promoter |
HNF4A,NOTCH1,HDAC1, |
3.47E-2 |
GO:0060284
|
regulation of cell development |
BCL2,NOTCH3,NOTCH1,HDAC1, |
3.72E-2 |
GO:0006916
|
anti-apoptosis |
BCL2,BIRC5,HDAC1,XIAP, |
3.78E-2 |
GO:0006275
|
regulation of DNA replication |
PDGFRA,NF2,GMNN, |
4.10E-2 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
HNF4A,MYCN,NOTCH1,HDAC1,SIRT1,HDAC8, |
4.37E-2 |
GO:0048754
|
branching morphogenesis of a tube |
BCL2,MYCN,NOTCH1, |
4.50E-2 |
GO:0046546
|
development of primary male sexual characteristics |
CCND1,BCL2,PDGFRA, |
4.50E-2 |
GO:0009991
|
response to extracellular stimulus |
CCND1,BCL2,SIRT1,ATG9A, |
4.54E-2 |
GO:0035295
|
tube development |
BCL2,MYCN,PDGFRA,NOTCH1, |
4.54E-2 |
GO:0010605
|
negative regulation of macromolecule metabolic process |
HNF4A,NF2,HDAC1,GMNN,SIRT1,HDAC8, |
4.56E-2 |
GO:0009968
|
negative regulation of signal transduction |
CCND1,HNF4A,NF2,SIRT1, |
4.60E-2 |
GO:0042524
|
negative regulation of tyrosine phosphorylation of Stat5 protein |
HNF4A,NF2, |
4.65E-2 |
GO:0032268
|
regulation of cellular protein metabolic process |
CCND1,HNF4A,BCL2,NF2,CDK4, |
5.54E-2 |
GO:0046661
|
male sex differentiation |
CCND1,BCL2,PDGFRA, |
5.64E-2 |
GO:0001763
|
morphogenesis of a branching structure |
BCL2,MYCN,NOTCH1, |
5.79E-2 |
GO:0010648
|
negative regulation of cell communication |
CCND1,HNF4A,NF2,SIRT1, |
6.34E-2 |
GO:0016310
|
phosphorylation |
CCND1,CDK6,BCL2,PDGFRA,CDK4,MET, |
6.57E-2 |
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
NF2,HDAC1,GMNN,SIRT1,HDAC8, |
7.26E-2 |
GO:0003006
|
reproductive developmental process |
CCND1,BCL2,PDGFRA,SIRT1, |
7.37E-2 |
GO:0051172
|
negative regulation of nitrogen compound metabolic process |
NF2,HDAC1,GMNN,SIRT1,HDAC8, |
7.61E-2 |
GO:0048589
|
developmental growth |
BCL2,NOTCH3,NOTCH1, |
7.93E-2 |
GO:0043193
|
positive regulation of gene-specific transcription |
HNF4A,NOTCH1,HDAC1, |
7.93E-2 |
GO:0009611
|
response to wounding |
HNF4A,BCL2,NOTCH3,PDGFRA,NOTCH1, |
8.19E-2 |
GO:0000075
|
cell cycle checkpoint |
CCND1,CCNE2,BIRC5, |
8.64E-2 |
GO:0010558
|
negative regulation of macromolecule biosynthetic process |
NF2,HDAC1,GMNN,SIRT1,HDAC8, |
9.14E-2 |
GO:0042532
|
negative regulation of tyrosine phosphorylation of STAT protein |
HNF4A,NF2, |
9.27E-2 |
GO:0031327
|
negative regulation of cellular biosynthetic process |
NF2,HDAC1,GMNN,SIRT1,HDAC8, |
9.97E-2 |
|
|
|
|
|
|